Skip to main content
Premium Trial:

Request an Annual Quote

New Product

Premium

Waters this week introduced a new UPLC analytical solution for the characterization of 2-AB labeled glycans from glycoproteins.

The solution combines new Acquity UPLC BEH Glycan columns with the Acquity UPLC system equipped with fluorescence detection.

In a statement, Waters said the solution is being introduced at the request of scientists who want to apply UPLC technology to the development and analysis of glycans derived from therapeutic proteins. Regulations from the US Food and Drug Administration require that companies developing and manufacturing therapeutic proteins be able to accurately characterize the glycan attached to those proteins in order to ensure efficacy and safety of a biopharmaceutical product.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.